What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Paul D.P. Pharoah mainly focuses on Breast cancer, Internal medicine, Genetics, Oncology and Genome-wide association study.
Breast cancer is a subfield of Cancer that he tackles.
In most of his Internal medicine studies, his work intersects topics such as Endocrinology.
Paul D.P. Pharoah interconnects Pathology, Genetic counseling, Penetrance, Tissue microarray and Genetic testing in the investigation of issues within Oncology.
His Genome-wide association study study necessitates a more in-depth grasp of Single-nucleotide polymorphism.
Paul D.P. Pharoah has researched Single-nucleotide polymorphism in several fields, including Case-control study, Polymorphism and Genetic variation.
His most cited work include:
- Genome-wide association study identifies novel breast cancer susceptibility loci (2045 citations)
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers (1368 citations)
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (951 citations)
What are the main themes of his work throughout his whole career to date?
Paul D.P. Pharoah mainly investigates Internal medicine, Breast cancer, Oncology, Single-nucleotide polymorphism and Genetics.
His study in Internal medicine focuses on Cancer, Odds ratio, Ovarian cancer, Case-control study and Prostate cancer.
His Cancer research integrates issues from Candidate gene, Endocrinology and Risk factor.
Paul D.P. Pharoah combines subjects such as Cancer research, Genetic predisposition and Bioinformatics with his study of Breast cancer.
His Oncology study integrates concerns from other disciplines, such as Disease, Pathology, Gynecology, Proportional hazards model and Hazard ratio.
Single-nucleotide polymorphism is a subfield of Genotype that Paul D.P. Pharoah studies.
He most often published in these fields:
- Internal medicine (47.52%)
- Breast cancer (44.36%)
- Oncology (43.12%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (47.52%)
- Oncology (43.12%)
- Breast cancer (44.36%)
In recent papers he was focusing on the following fields of study:
Paul D.P. Pharoah mostly deals with Internal medicine, Oncology, Breast cancer, Genome-wide association study and Cancer.
Many of his studies involve connections with topics such as Single-nucleotide polymorphism and Internal medicine.
The study incorporates disciplines such as Logistic regression, Genotyping and Gene–environment interaction in addition to Single-nucleotide polymorphism.
His Oncology research is multidisciplinary, relying on both Prostate, MEDLINE, Ovarian cancer, Disease and Genotype.
His Breast cancer research incorporates elements of Cancer research, Genetic variants, Germline and Hazard ratio.
His Genome-wide association study research is under the purview of Genetics.
Between 2018 and 2021, his most popular works were:
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
- Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. (135 citations)
- Discovery of common and rare genetic risk variants for colorectal cancer (131 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Internal medicine, Oncology, Breast cancer, Cancer and Genome-wide association study.
His research integrates issues of PALB2, Confidence interval, Proportional hazards model, Prostate cancer and Cohort in his study of Oncology.
His research in Breast cancer intersects with topics in Germline mutation, Bioinformatics, Genetic testing and Hazard ratio.
His Cancer study combines topics in areas such as Myeloid, Cancer research, CHEK2 and MEDLINE.
Genome-wide association study is the subject of his research, which falls under Single-nucleotide polymorphism.
His Case-control study research includes elements of Demography and Genotype.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
